Location History:
- Cherry Hill, NJ (US) (2019 - 2023)
- Piscataway, NJ (US) (2020 - 2024)
Company Filing History:
7 out of 22 
6 out of 8 
2 out of 13 Years Active: 2019-2024
Title: The Innovative Mind of Irfan A Mohammed
Introduction
Irfan A Mohammed is an accomplished inventor currently based in Cherry Hill, NJ, USA. With an impressive portfolio of 15 patents, his contributions to the field of pharmaceuticals, particularly in the area of atropine formulations, stand out. His innovative spirit and dedication toward improving medical treatments through his inventions have significantly impacted the industry.
Latest Patents
Among his notable achievements, Irfan has developed several patents focused on atropine pharmaceutical compositions. His inventive subject matter is directed toward creating compositions and methods for sterile and storage-stable low-dose atropine formulations that demonstrate improved stability. Most significantly, these compositions are substantially preservative-free, exhibiting less than 0.35% tropic acid resulting from the degradation of atropine. The formulations he has developed are advantageous as they are also substantially free of preservatives, underscoring his commitment to enhancing patient safety and drug efficacy.
Career Highlights
Throughout his career, Irfan A Mohammed has applied his expertise in various companies, most notably at Nevakar Inc. and Vyluma Inc. His work in these organizations has allowed him to cultivate a rich knowledge base while developing groundbreaking innovations that contribute to public health.
Collaborations
Irfan's career has also been marked by valuable collaborations with talented professionals in the field. Noteworthy coworkers include Kumaresh Soppimath and Navneet Puri, with whom he has worked alongside to further advance their shared goals in pharmaceutical innovation.
Conclusion
Irfan A Mohammed exemplifies the qualities of a visionary inventor. His patents, particularly in the realm of atropine formulations, showcase his commitment to creating safe and effective pharmaceutical options. As he continues to innovate, the field of medicine is likely to benefit from his ongoing contributions, marking him as a key figure to watch.